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Title: Rurality of medical provider and race of patient as risk factors for overdose in opioid use 
disorder populations  
Background  
This study examines the outcomes of medication assisted treatment (MAT) for opioid use 
disorders (OUD) based on location of treatment and race of the individual seeking treatment. 
Opioid use in the United States has been disproportionately rising in the last decade and there is 
evidence of unequal treatment based on different social disparities, namely rurality and race. 
Discriminatory distribution of medication and treatment for individuals seeking OUD along the 
lines of race and rurality is an issue of grave importance in both medical and ethical fields. 
Methods  
Individuals seeking treatment for OUD were identified and the use of MAT and/or mental health 
treatment (MHT) was analyzed. Data analysis of which course of treatment (MAT or MHT) 
were protective factors against overdose were analyzed. MAT most commonly used to treat 
OUD, buprenorphine, methadone, and naltrexone, were analyzed for risk of overdose following 
treatment seeking for OUD. Using administrative Medicaid data, persons with a first episode 
OUD diagnosis (N=9538) that were admitted to an emergency medical treatment facility in 
2016-2018 and had no previous claims for OUD were identified using ICD 10 diagnostic codes. 
The number that initiated medication within 30 days of diagnosis were identified, separated by 
type of prescription: naltrexone=564, methadone=117, buprenorphine=2722, and no MAT=6187. 
Demographic factors (age, race, zip code of housing, and gender) were obtained from patient 
records, and pharmacy claims following OUD diagnosis were used to determine MAT group 
(i.e., buprenorphine, naltrexone, methadone, or no MAT). Emergency department and hospital 
claims were used to identify overdoses in the year following OUD diagnosis, and Cox regression 
was used to analyze risk of overdose.  
Proposed Hypothesis  
We predict that being treated for OUD in rural areas or being of non-white race is a leading 
factor of an individual recieving care that leads to overdose following treatment for being 
diagnosed with OUD. 
 
 
